0001387131-20-004497.txt : 20200506
0001387131-20-004497.hdr.sgml : 20200506
20200506183812
ACCESSION NUMBER: 0001387131-20-004497
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200504
FILED AS OF DATE: 20200506
DATE AS OF CHANGE: 20200506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rhodes John B
CENTRAL INDEX KEY: 0001346251
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 20853995
MAIL ADDRESS:
STREET 1: 74 FIFTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 509 MADISON AVE. - SUITE 1608
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 1-800-849-7894
MAIL ADDRESS:
STREET 1: 509 MADISON AVE. - SUITE 1608
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2020-05-04
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001346251
Rhodes John B
C/O TONIX PHARMACEUTICALS HOLDING CORP.
509 MADISON AVENUE, SUITE 1608
NEW YORK
NY
10022
1
0
0
0
Stock Option
0.77
2020-05-04
4
A
0
75000
0.00
A
2021-05-04
2030-05-04
Common Stock
75000
75000
D
The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
/s/ Jessica Morris, Attorney-in-Fact
2020-05-06